Products
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
CENTRO DE DIABETES CURITIBA LTDA
🇧🇷
Brazil
Country
🇧🇷
Brazil
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Effect of Anti-diabetic Drugs on Glycemic Variability
Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Drug: Gliclazide MR
Drug: Dapagliflozin
Subscribe
First Posted Date
2016-10-06
Last Posted Date
2020-03-04
Lead Sponsor
Centro de Diabetes Curitiba Ltda
Target Recruit Count
135
Registration Number
NCT02925559
Locations
🇧🇷
Centro de Diabetes Curitiba, Curitiba, Parana, Brazil
Subscribe
Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability
Phase 4
Completed
Conditions
Osteoporosis
Type 2 Diabetes Mellitus
Menopause
Osteopenia
Interventions
Drug: Gliclazide MR
Drug: Vildagliptin
Subscribe
First Posted Date
2012-09-06
Last Posted Date
2016-11-04
Lead Sponsor
Centro de Diabetes Curitiba Ltda
Target Recruit Count
56
Registration Number
NCT01679899
Locations
🇧🇷
Centro de Diabetes Curitiba, Curitiba, Parana, Brazil
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy